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Abstract
Three dimensional speckle tracking echocardiography (3D-STE) is a novel modality for the assessment of left ventricular 
strain (LVS). The aim of our study is to provide single vendor normative strain values measured with 3D-STE in healthy 
adult caucasians. One hundred fifty-five healthy subjects aged 20 to 72 years (≥ 28 subjects per decile) were prospectively 
included and examined with 2D and 3D transthoracic echocardiography. In 105 both 3D and 2D-STE were feasible (71%, 
mean age 44 ± 14 years, 51% female). Mean 3D tangential strain (3D-TS) was − 32 ± 2.9%. 3D global longitudinal strain 
(3D-GLS) demonstrated a significant but not very strong correlation with 2D-GLS values (− 19.7 ± 1.8% vs − 20.4 ± 2.2%, 
r = 0.462, p < 0.001). No gender difference was observed in 3D strain parameters. 3D-GLS decreased with increasing age 
stratum (p = 0.024). LVEF was associated with 3D-TS and 3D-GLS (r =  − 0.819, p ≤ 0.001 for 3D-TS, p =  − 0.477, r < 0.001, 
p = 0.001 for 3D-GLS). In this single vendor study age and gender-specific normative LV 3D-TS values were reported for 
healthy adult caucasians. In a significant proportion of the subjects 3D-STE was not feasible, but when feasible, 3D-STE 
shows excellent association with LVEF, and is therefore a promising novel modality for the assessment of the myocardial 
function, provided that issues of limited feasibility and temporal resolution are addressed.
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Introduction
Speckle-tracking echocardiography (STE) is a novel imag-
ing modality that allows quantitative assessment of global 
and segmental left ventricular (LV) myocardial function 
by measuring LV strain (LVS) in a manner largely inde-
pendent of angle and ventricular geometry [1]. Myocardial 
deformation measurements allow early diagnosis of LV dys-
function by facilitating better risk stratification, reclassifica-
tion and treatment in patients with cardiovascular disease 
[2]. 2D-STE, which is the established echocardiographic 
modality for LVS analysis, has the inherent limitations of 
planar simplification and apical foreshortening [3].
3D-STE has been developed with the aim of overcom-
ing the technical limitations associated with 2D-STE. This 
technique allows tracking of speckle patterns that move 
out of the imaging plane. A novel myocardial deformation 
parameter, 3D tangential strain (3D-TS), which is defined as 
the greater of the 2 deformation values along the 2 diago-
nals of the quadrangular endocardial units formed by the 
analysis software (Fig. 1),could also be calculated with this 
modality [4]. Several studies, the largest being the NORRE 
study by the European Association of Cardiovascular Imag-
ing (EACVI), have evaluated the LVS patterns by 3D-STE 
in healthy adults. Reference ranges in healthy adults were 
proposed, and age and gender-related distribution patterns 
of these parameters were described [5, 6].
The previous studies demonstrated significant differences 
in LVS values. These differences are attributed to the ultra-
sound (US) system [7], STE analysis software [8], and the 
population studied [5]. A recent meta-analysis demonstrated 
that both software vendor, US system and the population 
 * Annemien E. Van den Bosch 
 a.e.vandenbosch@erasmusmc.nl
1 Department of Cardiology, Erasmus University 
Medical Center, P.O. Box 2040, 3000 CA Rotterdam, 
The Netherlands
2 Department of Cardiology, Erasmus University 
Medical Center, Room Rg-433,‘s-Gravendijkwal 230, 
3015 CE Rotterdam, The Netherlands
 The International Journal of Cardiovascular Imaging
1 3
studied were independently associated with the variability 
in the LVS values measured by 3D-STE [6]. The NORRE 
study, the largest cohort of 3D-STE data on healthy indi-
viduals, used the Tomtec software (Tomtec, TomTec Imag-
ing Systems, Unterschleissheim, Germany) for STE analysis. 
Two different US systems, Philips (Philips Medical Systems, 
Best, the Netherlands) and GE (GE Vingmed Ultrasound 
AS, Horten, Norway), were used for image acquisition in 
this study. The selected image acquisition and STE analysis 
system varies from study to study, and makes the compa-
rability and interpretation of the results difficult. There is 
a need for population specific, single US system and single 
analysis software data on healthy individuals.
In the current study, our aim was threefold: (1) to pro-
vide normative values for 3D-STE in a cohort of healthy 
adult caucasians aged 20–72 years, obtained with a single-
vendor US (Philips) and STE analysis platform (Tomtec) (2) 
to compare the feasibility and the distribution of the 2D and 
3D-STE derived LVS; (3) and to evaluate the association of 
3D-STE derived LVS patterns with baseline characteristics 
of the study participants.
Materials and methods
Study population
This prospective cohort study was conducted in 2014–2015 
in 155 healthy volunteers aged 20 to 72 years, who were 
stratified into 5 age groups: 20 to 29, 30 to 39, 40 to 49, 50 
to 59, and 60 to 72 years (n ≥ 28 in each group, equal distri-
bution in sex). The subjects were recruited via an advertise-
ment for healthy subjects. The inclusion criteria required 
that subjects had normal results on physical examination and 
electrocardiography (ECG). Subjects were excluded when 
they met any of the following criteria: prior cardiovascular 
disease; cardiovascular risk factors consisting of hyperten-
sion, diabetes mellitus or hypercholesterolemia; systemic 
disease or medication known to influence cardiac function; 
or the finding of cardiac abnormalities during examination. 
Professional athletes, morbidly obese subjects (body mass 
index, BMI > 40 kg/m2), pregnant women and women with 
breast implants were also excluded.
Clinical assessment
The assessment consisted of physical examination, 12-lead 
ECG, and echocardiography. Physical examination included 
height, weight, blood pressure, saturation, and results of 
heart, lungs and abdominal findings.
Echocardiographic image acquisition
All echocardiographic studies were performed by 2 experi-
enced sonographers. Two-dimensional greyscale harmonic 
images were obtained in the left lateral decubitus position 
using an iE33 or EPIQ7 ultrasound system (Philips Medi-
cal Systems, Best, the Netherlands) equipped with a tran-
sthoracic broadband X5-1 matrix transducer (composed of 
3040 elements with 1–5 MHz). Standard apical 4-chamber 
(A4C), 2-chamber (A2C) and 3-chamber (A3C) views were 
obtained for STE at frame rates of ≥ 50 frames/sec. Real-
time 3D-TTE was performed immediately after the 2D-TTE 
with the same ultrasound unit and transducer. A minimum 
4-beat full volume dataset of the LV was acquired from the 
apical window during a single breath hold. The acquired 
images were transferred to the analysis software on a dedi-
cated workstation. Conventional echocardiographic meas-
urements including detailed left atrial mitral inflow and pul-
monary vein inflow measurements were performed using 
the proprietary software of the echocardiography machine 
[9–11]. 2D-STE and 3D-STE analyses were performed using 
Image Arena version 4.6 (TomTec Imaging Systems, Unter-
schleissheim, Germany) by 2 investigators experienced in 
the field (FOM) and (DB). The data sets were blinded for the 
observers. The average peak endocardial strain values given 
by the software were exported to a spreadsheet program.
Fig. 1  LV model: Software 
generated polygon mesh of the 
LV endocardial surface formed 
by connecting 16 longitudinal 
and 32 circumferential vertices 
(red dots) with edges (connect-
ing lines). D1 and D2 diagonals 
of an endocardial polygon unit, 
3D-TS tangential strain
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Conventional echocardiographic measurements
We used the current guidelines of the American Society of 
Echocardiography and EACVI for chamber quantification 
[12]. From the A4C, pulsed-wave Doppler examination was 
performed to obtain peak mitral inflow velocities at early 
(E) and late (A) diastole and E-wave deceleration time (DT). 
Tissue Doppler imaging (TDI) was performed to obtain 
myocardial tissue velocity at the septal mitral annulus at 
early diastole (E’). 2D LV end-diastolic volume (LVEDV), 
LV end-systolic volume (LVESV) and LVEF were derived 
with the biplane method of disks based on one cardiac cycle.
2D‑STE strain analysis
2D Cardiac Performance Analysis package of the Tomtec 
software was used for 2D-STE. The 2D-STE was defined 
as feasible when all the strain parameters were retrievable 
and the number of poorly tracking or non-tracking seg-
ments was ≤ 2. Cardiac cycles were defined by the position 
of the R-waves. End-diastole was tagged at the frame cor-
responding to peak of R wave. End-systole was tagged at 
the first frame at which LV has the minimal size following 
the reference R wave. The endocardial borders were manu-
ally traced in the A4C, A3C and A2C for the LS and in the 
mid-papillary level short-axis images for radial and circum-
ferential strain. After the manual tracing, the software auto-
matically tracked the endocardial border. Manual corrections 
were made when necessary. Peak systolic strain values were 
defined as the peak values on the curves during the ejection 
phase of one cardiac cycle. The 2D average global longitu-
dinal strain, mid-papillary level average circumferential and 
radial strain (2D-MS-CS, 2D-MS-RS), LVEDV, LVESV and 
LVEF values were obtained.
3D‑STE strain analysis
4D LV-analysis package of the Tomtec software was used 
for 3D-STE analysis. The software processed the 3D full 
volume dataset and produced the 2, 3 and 4 chamber views 
automatically. In the respective panels displaying these 
views, an axial line segment was aligned by the operator 
manually so that it was positioned between the center point 
of the mitral annulus and the LV apex. The software auto-
matically traced the LV endocardium frame-by-frame in the 
next step. Manual corrections were made on the automati-
cally traced endocardial borders as needed, in the end-sys-
tolic and end-diastolic frames. Finally, the software gave the 
peak and end-systolic 3D-TS, 3D-GLS, 3D-GCS, 3D-GRS, 
twist and torsion values as well as 3D-LVEDV, 3D-LVESV 
and 3D-LVEF. The analysis software derives the radial strain 
measurements from the endocardial area, according to the 
principle of volume conservation. Circumferential strain is 
derived from the endocardial border [13]. Tracking quality 
was classified as excellent, good or fair, and the signal to 
noise ratio was classified as good or bad, subjectively by 
the operator. 3D-STE analysis was defined as feasible when 
all the strain parameters were retrievable and the number of 
poorly tracking or non-tracking segments was ≤ 2 (Fig. 2) 
[4].
Statistical analysis
The data distribution was tested using histograms and the 
Shapiro–Wilk test. Continuous data were presented as 
mean ± standard deviation (SD). Categorical data was pre-
sented as frequencies and percentages. For comparison of 
normally distributed continuous between two groups with 
the Student’s t-test. In case of skewed distribution, the 
Mann–Whitney-U test was applied instead of t-test. For 
comparison of frequencies the χ2-test was used. For com-
parison of distribution of continuous variables between age 
strata, one-way ANOVA test was used. Analysis of correla-
tion was performed with Pearson’s correlation coefficient. 
Multiple linear regression analysis was used for determining 
independent effect of predictors which were included in the 
prediction model. Two-tailed tests were used for correla-
tion analysis and complete case analysis was the preferred 
method.
Intra-observer agreement was assessed by repeated analy-
sis in a sample of 20 subjects (n = 4 per decile, randomly 
selected) > 1 month after the initial analysis, in randomly 
mixed order, and blinded to the initial results. Assess-
ment of inter-observer agreement was performed by the 
second investigator (DB) in the same sample. The agree-
ment between 2 measurements was determined by correla-
tion analysis with scatter plots and Bland–Altman analysis 
with Bland–Altman plots for determination of intra and 
inter-observer variabilities. All statistical analyses were 
performed using SPSS statistics version 25 (IBM Corp., 
Armonk, NY, USA). A p value of less than 0.05 was con-
sidered statistically significant.
Results
Study population
Of the 155 subjects who came to our medical center, 147 
were included in this study (age 45 ± 14  years, 50.3% 
female). Eight subjects were excluded due to limited echo-
cardiographic acoustic windows (n = 2), valve pathology 
(n = 2), surgically closed patent ductus arteriosus (n = 1), 
hypertension (n = 1), morbid obesity (n = 1), and right bun-
dle branch block on ECG (n = 1) [9]. Table 1 shows the char-
acteristics of the study population.
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Feasibility, temporal resolution and image quality
3D-STE was feasible in 117 of the 147 participants (79.6%) 
while 2D-STE was feasible in 130 participants (88.4%) 
(p < 0.001). When the patients in whom 3D-STE was feasi-
ble and non-feasible were compared, 3D-STE feasible par-
ticipants had a greater BMI and a lower E-wave amplitude 
(Table 1). In 105 participants (71.4%) both 3D and 2D-STE 
were feasible and were included in the further analyses. 
Frame rates of the echocardiographic images were lower 
for 3D-STE compared with 2D-STE (30 ± 10 vs 60 ± 11 Hz, 
p < 0.001). Majority of the participants demonstrated good 
tracking quality (n = 58, 55.2%) and good signal to noise 
ratio (n = 78, 74.3%). Fourty-nine participants (47%) had at 
least one poorly tracked or non-tracked segments. The seg-
ments commonly associated with tracking problems were 
basal antero-septum, infero-septum and infero-lateral seg-
ments (Table 2).
LV strain
3D strain values are shown in Table 3, the distribution 
of the values in age and gender strata is shown in Fig. 3. 
Mean 3D-TS was − 32 ± 2.9% in the total study population. 
There were no significant gender-related differences with 
3D-STE strain analysis. Among 3D strain parameters, only 
3D-GLS decreased with increasing age strata (p = 0.024). 
3D-LVEDV and 3D-LVESV were lower in female partici-
pants while 3D-LVEF did not differ between genders. The 
3D-GLS values were lower compared with 2D-GLS values 
(− 19.7 ± 1.8% vs − 20.4 ± 2.2%, p = 0.001) (Fig. 4a). There 
was a statistically significant, but moderate correlation 
with a bias of − 0.7 ± 2.1 between 3D-GLS and 2D-GLS 
(r = 0.462, p < 0.001) (Fig. 4b, c).
Variables associated with 3D‑TS and 3D‑GLS
Results of the univariate and multivariate analyses are 
summarized in Table 4. In univariate analysis, lower end-
diastolic intraventricular septum diameter (IVSd) (r = 0.229, 
p = 0.021), LVESV (r = − 0.419, p < 0.001) and LVEF 
(r = − 0.819, r < 0.001) were associated with 3D-TS. In 
a model consisting of age, systolic blood pressure, PWd, 
E wave, E’ wave amplitude and LVEF, only LVEF was 
independently associated with 3D-GLS (USβ = − 0.156, 
Sβ = − 0.346,  R2 = 0.307, p = 0.001). Diastolic blood pres-
sure demonstrated a strong correlation with systolic blood 
pressure, and E/A had a strong correlation with E wave 
amplitude. Thus, these 2 parameters were excluded from the 
model. Previous studies suggest that the effect of heart rate 
on myocardial strain is mainly via the changes in volumes 
and contractility. This parameter was also excluded from 
the model as a result. Multivariate analysis was not per-
formed for 3D-TS, because the 3 predictors, IVSd, LVESV 
and LVEF correlated significantly with each other. 
Fig. 2  Evaluation of 3D-TS with the use of Tomtec 4D-LV Quantification package. The global average 3D-TS value in this patient was − 28.1%
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Intra‑observer and inter‑observer agreement
The intra-observer variability was − 1.1 ± 2.7% and the inter-
observer variability was − 2.5 ± 3.1% for 3D-TS. The intra 
and inter-observer variabilities for 3D-GLS were − 0.9 ± 2% 
and − 1 ± 2.1% (Fig. 5).
Discussion
The current study presented normative values for 3D-STE 
strain variables for a healthy caucasian population. The fea-
sibility of 3D-STE was lower than 2D-STE. The 3D-GLS 
values correlated significantly with 2D-GLS. LVEF was the 
only baseline characteristic that was associated with both 
3D-TS and 3D-GLS.
3D‑STE: normative data
The mean 3D-STE strain values were similar to published 
data on the same population [8], however lower than the 
multinational registries [5], despite similar BMI values. 
Normative ranges of 2D transthoracic echocardiography 
parameters were higher compared with the other popula-
tions in previous studies. This findings were explained with 
anthropometric characteristics, since Dutch people are the 
tallest of the world [9]. Larger body surface area with larger 
acoustic window might be expected to increase accuracy 
of the measurements. Conversely, larger lung tissue, larger 
BMI with resultant increase in subcutaneous adipose tissue 
might decrease the image quality and the accuracy of the 
strain measurements. Previously increased body size was 
Table 1  Characteristics of the 
study population
Bold correspond to the parameters with values with a significant difference between comparison groups 
(P < 0.05)
LV left ventricle, EDD end-diastolic diameter, ESD end-systolic diameter, ESV end-systolic volume, EDV 
end-diastolic volume, ESVI and EDVI values indexed to body surface area. Values are presented as n (%) 
or mean ± SD. E peak mitral inflow velocity at early diastole, A peak mitral inflow velocity at late diastole, 
E’ = early diastolic annular myocardial velocity, LV = left ventricle, BSA body surface area
a Volumes and ejection fraction in this table are calculated by biplane method of disks
Characteristic All patients Patients in whom 3D and 2D-STE 
are both feasible
P
(n = 147) Yes (n = 105) No (n = 42)
Sex, female 74 (50.3%) 56 (50.9%) 18 (48.6%) 0.277
Age (years) 45 ± 14 44 ± 14 47 ± 14 0.140
Current smoker 13 (8.8%) 8 (7.6%) 5 (11.9%) 0.520
Physical examination
 Body mass index (kg/m2) 24.4 ± 3.3 23.9 ± 2.9 25.5 ± 3.9 0.008
 Body surface area  (m2) 1.89 ± 0.19 1.88 ± 0.19 1.93 ± 0.20 0.104
 Systolic blood pressure (mmHg) 127 ± 15 126 ± 14 129 ± 15 0.287
 Diastolic blood pressure (mmHg) 80 ± 9 79 ± 9 80 ± 9 0.569
ECG
 Sinus rhythm 147 (100%) 110 (100%) 37 (100%) –
 Heart rate (bpm) 62 ± 10 61 ± 10 62 ± 9 0.741
 PR interval (ms) 159 ± 22 158 ± 23 160 ± 20 0.726
 QRS duration (ms) 96 ± 9 96 ± 9 96 ± 10 0.855
Echocardiography, left ventricle
 EDD (mm) 45 ± 4 45 ± 4 46 ± 4 0.354
 ESD (mm) 28 ± 4 28 ± 4 28 ± 5 0.610
 E wave (m/s) 0.69 ± 0.16 0.72 ± 0.16 0.62 ± 0.13  < 0.001
 A wave (m/s) 0.49 ± 0.15 0.49 ± 0.15 0.50 ± 0.16 0.688
 Deceleration time (ms) 190 ± 41 188 ± 40 195 ± 42 0.357
 E/E’-ratio 8 ± 2 8 ± 2 8 ± 2 0.739
 LVEDV (mL)a 119 ± 26 118 ± 26 120 ± 24 0.765
 LVESV (mL)a 47 ± 13 47 ± 14 49 ± 13 0.289
 LVEDVI (mL/m2)a 62 ± 10 63 ± 10 62 ± 9 0.628
 LVESVI (mL/m2)a 25 ± 6 25 ± 6 25 ± 5 0.502
 LVEF, biplane (%)a 60 ± 5 61 ± 5 59 ± 4 0.033
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found associated with decreased strain measurements using 
B-mode strain [14]. Population-specific genetic, structural 
or physiological characteristics other than anthropometric 
measures might also result in these differences.
The variability might alternatively result from the US-
system or the STE analysis software. Gayat et al. demon-
strated that US vendor (Toshiba versus Philips) was associ-
ated with variability in strain values [15]. Factors related 
with the US system such as probe specifications and image 
processing, and differences in temporal and spatial resolu-
tion of the system, as well as differences resulting from strain 
definitions (tangential vs area), region of interest selection 
(endocardial vs full thickness) and temporal definitions (ie. 
timing of the end-systole and end-diastole) are the potential 
sources of variability (Appendix 2) [16]. The EACVI-ASE 
Strain Standardization Task Force provides ongoing work in 
characterizing the inter-vendor variability and standardiza-
tion of strain imaging with STE [17].
3D‑STE versus 2D‑STE
Along with the solution of geometric simplification and 
apical shortening, 3D-STE is equipped with the capability 
of producing novel 3D strain measures such as 3D-TS [4]. 
Nevertheless, limited temporal resolution is a well-known 
limitation of 3D-STE, when compared with 2D-STE. Rec-
ommended frame rate is 40 to 80 Hz for 3D-STE, although 
reported frame rates are usually lower [6]. Frame rates 
achieved with 3D-STE in our study were similar to the val-
ues obtained in previous studies but below the recommended 
range as well as the frame rates achieved by 2D-STE.
We compared measurement of GLS, the LV strain 
parameter with the most robust evidence, with 2D-STE and 
3D-STE. 3D-GLS demonstrated significant correlation with 
2D-GLS. The normative range of 3D-GLS was significantly 
lower than with 2D-GLS, which is consistent with the pre-
vious findings [18]. In a recent study apical foreshortening 
resulted in up to 23% overestimation in 2D-STE [3]. Lower 
3D-GLS values compared with 2D-GLS in this study might 
be the result of a more accurate localization of the apex. 
We suggest that 3D-GLS could be implemented in measure-
ment of GLS, but the validated reference ranges for 2D-GLS 
should not be used interchangeably with 3D-GLS.
Relationships of 3D‑STE with age, sex and LVEF
Previous studies have found an age-related decrease in 
3D-GLS [8, 19]; however, large scale studies and meta-
analyses failed to confirm these patterns [20]. In our study, 
3D-GLS decreased, while 3D-GCS and 3D-GRS did not 
change with increasing age. 3D-GLS was not associated, and 
the remaining 3D strain parameters were weakly associated 
with age in the recent NORRE study [5]. Different studies 
have shown a decreased [21], or increased [19] 3D-GCS and 
3D-GRS values with increasing age.
LVS values has been found higher in women in previ-
ous studies [5]. This is usually attributed to higher LVEF 
in women [9]. However, a recent meta-analysis failed to 
demonstrate this difference [6]. The differences in 3D strain 
values were not statistically different between genders in 
this study. This finding paralleled similar 3D-LVEF val-
ues between genders. Lack of replicability in the age and 
gender-related changes among previous studies and also 
the current one has been attributed to the complex interplay 
between population-specific and vendor-specific factors. It 
is suggested that gender-related differences in LV strain was 
attributed to differences in body size between genders using 
B-mode strain measurements. Populations with closer body 
size ranges between genders might have closer LV strain val-
ues [14]. Breast tissue in women sometimes makes localiza-
tion of the true apex difficult. Resulted foreshortening might 
also result in higher values in women [3].
Another possible factor underlying this variability is 
sample size. Especially for cohorts that consist of healthy 
individuals, distribution range of both strain and volumetric 
parameters is narrower. As a result, retrieving significant 
test results would require considerably large sample sizes 
in such studies. The statistically nonsignificant but higher 
3D-TS and 3D-GLS and 3D-LVEF values in women, and 
lower 3D-TS, 3D-LVEDV and 3D-LVEF with increased age 
might be associated with these last 2 factors. The large inter-
national registries [5] as well as studies on populations with 
different ethnic background, will delineate ethnic as well as 
age and gender-related differences with regard to myocardial 
deformation patterns.
Table 2  Three-dimensional speckle tracking echocardiography image 
quality
Values are presented as n (%) or mean ± SD
n = 105
Tracking quality
 Excellent 33 (31.4%)
 Good 58 (55.2%)
 Fair 14 (13.3%)
Signal to noise ratio
 Good 78 (74.3%)
 Bad 27 (25.7%)
Non-tracking or poorly tracking segments
 Basal antero-septum 26 (24.8%)
 Basal infero-septum 26 (24.8%)
 Basal infero-lateral 6 (5.7%)
Number of non-tracking or poorly tracking segments
 0 56 (53.3%)
 1 25 (23.8%)
 2 24 (22.9%)
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LVEF was the only factor associated with both 3D-TS 
and 3D-GLS. This finding is in accordance with the findings 
from other studies in healthy individuals [5]. When 3D-STE 
and 2D-STE are compared, 3D-TS and 3D-GLS correlated 
stronger with LVEF compared with 2D-GLS in previous 
studies [22]. GLS is a sensitive marker of LV global sys-
tolic function and might be impaired in subclinical cardiac 
damage, when LVEF is within normal limits [8]. However, 
in healthy individuals without cardiovascular disease, GLS 
is expected to correlate better with LVEF. We demonstrated 
that 3D-TS and 3D-GLS are sensitive to changes in LVEF 
values within normal range in healthy adults.
Feasibility and reproducibility
The patients for the current study were initially enrolled for 
2D-STE. The feasibility of 3D-STE reported herein might 
reflect the real-world experience better as a result. Yet, the 
feasibility of 3D-STE in our study was higher than some of 
the reported values as low as 71% [23]. Higher BMI is asso-
ciated with decreased transthoracic echocardiography image 
quality. Resultant decreased feasibilty was demonstrated in 
the current study. Lower E wave amplitude in the 3D-STE 
nonfeasible group might be associated with increased BMI 
[24].
The reproducibility of 3D-TS and 3D-GLS was accept-
able [8]. The manual corrections performed during the 
Fig. 3  Distribution of 3D strain values in age and gender strata. TS tangential strain, GLS global longitudinal strain, GCS global circumferential 
strain, GRS global radial strain. Error bars represent 95% confidence interval of the mean
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endocardial tracing is an important source of variability for 
3D-STE. Implementation of fully automated border tracking 
and machine-learning algorithms by the 3D-STE systems 
will potentially eliminate the problems related with repro-
ducibility in the future [25].
Limitations of the study
The software platform used for 3D-STE only allows endo-
cardial strain analysis. 3D-STE analysis package didn’t allow 
exclusion of non-tracking or poorly-tracking segments. An 
approach focusing on global average values was preferred as 
a result. Demonstration of the intervendor variability would 
have had incremental role in this study. However, we think 
that only inter-vendor agreement, but not the validity of a 
certain vendor, could be assessed in such a study, since there 
is no currently available noninvasive gold standard that the 
in-vivo accuracy of the available platforms could be tested 
against.
Fig. 4  a Distribution of 3D-TS, 3D-GLS, 2D-GLS in the study popu-
lation b Scatter plot graph demonstrating correlation of 3D-GLS and 
2D-GLS measurements c Bland–Altman graph demonstrating agree-
ment between of 3D-GLS versus 2D-GLS measurements. Error bars 
represent 95% confidence interval of the mean, r Pearson’s r coeffi-
cient, TS tangential strain, GLS global longitudinal strain
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Table 4  Univariable and 
multivariable analyses of left 
ventricular 3D global strain and 
3D global longitudinal strain
Bold correspond to the parameters with values with a significant difference between comparison groups 
(P < 0.05)
3D-TS 3 dimensional tangential strain, GLS global longitudinal strain, USβ unstandardized β coefficient, 
Sβ standardized β coefficient, LVIVSd left ventricle interventricular septum thickness, LVPWd LV posterior 
wall thickness, LVEDV LV end-diastolic volume, LVESV LV end-systolic volume, LVEF LV ejection frac-
tion
a volumes and LVEF in this value are measured by 3D-STE
3D-TS 3D-GLS
Univariate analysis Univariate analysis Multivariate analysis
r p R p USβ Sβ P
Age (years) 0.089 0.366 0.285 .003  − 0.003  − 0.027 .837
Sex (female) 0.209 .103
Physical examination
Body surface area  (m2) 0.094 0.341 0.134 .174
Systolic blood pressure (mmHg) 0.160 0.105 0.291 .003 0.019 0.153 .117
Diastolic blood pressure (mmHg) 0.199 0.042 0.271 .005
ECG
Heart rate (bpm) 0.105 0.287 0.207 .034
QRS duration (ms)  − 0.035 0.719 0.018 .857
Echocardiography, left ventricle
 IVSd 0.229 0.021 0.216 .029
 PWd 0.224 0.024 0.229 .021 0.003 0.002 .986
 End-systolic dimension (mm) 0.105 0.288 0.063 .522
 End-diastolic dimension (mm)  − 0.019 0.844  − 0.123 .213
 E wave (m/s)  − 0.218 0.025  − 0.387  < 0.001  − 0.124  − 0.011 .922
 A wave (m/s)  − 0.104 0.291 0.015 0.883
 Deceleration time (ms)  − 0.098 0.322  − 0.002 0.983
 E’ (cm/s)  − 0.160 0.106  − 0.412  < 0.001  − 0.188  − 0.269 .054
 E/A-ratio  − 0.035 0.724  − 0.259 0.008
 E/E’-ratio  − 0.012 0.903 0.183 0.065
 LVEDV (mL)a 0.163 0.096  − 0.020 0.842
 LVESV (mL)a  − 0.419  < 0.001 0.157 0.111
 LVEF (%)a  − 0.819  < 0.001  − 0.477  < 0.001  − 0.156  − 0.346 .001
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Fig. 5  Intraobserver and interobserver analysis for 3D-TS (a, b) and 3D-GLS (c, d), respectively. TS tangential strain, GLS global longitudinal 
strain, SD standard deviation
Conclusion
Age and sex-related changes as well as normative values 
were provided in this single US system, single analysis soft-
ware study on healthy adult Caucasians. 3D-STE demon-
strated reasonable feasibility and excellent agreement with 
LVEF. 3D-STE should be implemented in clinical evaluation 
of the LV function. The findings herein support interpreta-
tion of 3D-STE based myocardial deformation with ven-
dor- and population-specific reference ranges. The 3D strain 
values should not be used and interpreted interchangeably 
with 2D strain values.
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Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
Table 5  Characteristics of the study population, according to age and gender strata
Bold correspond to the parameters with values with a significant difference between comparison groups (P < 0.05)
Values are presented as n (%) or mean ± SD
E peak mitral inflow velocity at early diastole, A peak mitral inflow velocity at late diastole, E early diastolic annular myocardial velocity, BSA 
body surface area
Characteristic Sex p Age group (years) p
Female Male 20–29
n = 32
30–39
n = 28
40–49
n = 28
50–59
n = 31
60–72
n = 28
Sex, female – – 16 (50%) 14 (50%) 14 (50%) 16 (50%) 14 (50%)
Age (years) 45 ± 14 44 ± 14 .581 26 ± 2 35 ± 3 44 ± 3 54 ± 3 64 ± 3  < .001
Current smoker 8 (12%) 5 (8%) .569 2 1 4 5 1 .329
Physical examination
 Body mass index (kg/m2) 23.5 ± 3 25.2 ± 3.3 .002 22.3 ± 2.1 24 ± 3.4 24.6 ± 3.7 25.3 ± 2.8 25.8 ± 3.2  < .001
 Body surface area  (m2) 1.76 ± 0.12 2.03 ± 0.15  < .001 1.83 ± 0.17 1.89 ± 0.18 1.92 ± 0.22 1.91 ± 0.18 1.90 ± 0.19 .370
 Systolic blood pressure 
(mmHg)
123 ± 12 131 ± 16 .001 124 ± 13 131 ± 10 123 ± 12 130 ± 15 136 ± 17  < .001
 Diastolic blood pressure 
(mmHg)
77 ± 9 82 ± 9  < .001 76 ± 8* 78 ± 7 79 ± 9 83 ± 11 83 ± 8 .005
ECG
 Sinus rhythm
  Heart rate (bpm) 63 ± 8 60 ± 10 .066 61 ± 11 60 ± 8 62 ± 9 65 ± 10 65 ± 10 .372
  PR interval (ms) 155 ± 22 163 ± 21 .029 155 ± 23 150 ± 21 156 ± 24 159 ± 16 172 ± 18  < .001
  QRS duration (ms) 92 ± 7 100 ± 9  < .001 96 ± 8 97 ± 9 97 ± 9 94 ± 10 97 ± 9 .849
Echocardiography, left ventricle
 End-diastolic dimension (mm) 44 ± 4 46 ± 4 .002 46 ± 3 47 ± 3 45 ± 4 45 ± 4 44 ± 5 .051
 End-systolic dimension (mm) 27 ± 4 29 ± 4 .026 28 ± 3 28 ± 3 28 ± 5 28 ± 4 28 ± 6 .990
 E wave (m/s) 0.72 ± 0.17 0.66 ± 0.14 .006 0.80 ± 0.16* 0.75 ± 0.16 0.66 ± 0.15 0.65 ± 0.10 0.59 ± 0.13  < .001
 A wave (m/s) 0.51 ± 0.16 0.48 ± 0.14 .229 0.39 ± 0.14* 0.43 ± 0.08 0.47 ± 0.10 0.56 ± 0.12 0.62 ± 0.17  < .001
 Deceleration time (ms) 186 ± 31 194 ± 49 .191 177 ± 29 181 ± 32 185 ± 29 194 ± 31 216 ± 63 .001
 E’ (cm/s) 9.5 ± 2.7 9.4 ± 2.4 .680 12.4 ± 1.8 10.4 ± 1.6 9.2 ± 1.6 8.2 ± 1.8 6.8 ± 1.7  < .001
 E/A-ratio 1.6 ± 0.7 1.5 ± 0.6 .443 2.3 ± 0.8 1.8 ± 0.4 1.4 ± 0.4 1.2 ± 0.3 1.0 ± 0.3  < .001
 E/E’-ratio 7.9 ± 2 7.3 ± 1.7 .039 6.4 ± 1.3 7.3 ± 1.5 7.3 ± 1.7 8.1 ± 1.4 9.0 ± 2.4  < .001
 End-diastolic volume (mL) 103 ± 18 134 ± 22  < .001 117 ± 23 119 ± 23 125 ± 30 116 ± 21 116 ± 30 .704
 End-systolic volume (mL) 39.9 ± 10 55 ± 12  < .001 47 ± 11 47 ± 13 51 ± 12 45 ± 12 48 ± 16 .462
 End-diastolic volume / BSA 
(mL/m2)
58 ± 9 66 ± 9  < .001 64 ± 9 63 ± 10 64 ± 11 60 ± 8 61 ± 12 .492
 End-systolic volume/BSA (mL/
m2)
23 ± 5 27 ± 5  < .001 25 ± 5 25 ± 6 26 ± 5 23 ± 5 25 ± 7 .370
 Ejection fraction, biplane (%) 62 ± 5 59 ± 4  < .001 60 ± 4 61 ± 5 59 ± 4 62 ± 5 59 ± 4 .099
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
Appendix
Appendix 1
See Table 5.
The International Journal of Cardiovascular Imaging 
1 3
Appendix 2
See Table 6.
References
 1. Voigt JU, Cvijic M (2019) 2- and 3-dimensional myocardial 
strain in cardiac health and disease. JACC Cardiovasc Imaging 
12(9):1849–1863
 2. Cikes M, Solomon SD (2015) Beyond ejection fraction: an inte-
grative approach for assessment of cardiac structure and function 
in heart failure. Eur Heart J 37(21):1642–1650
 3. Unlu S et al (2020) Impact of apical foreshortening on defor-
mation measurements: a report from the EACVI-ASE Strain 
Standardization Task Force. Eur Heart J Cardiovasc Imaging 
21(3):337–343
 4. Pedrizzetti G et al (2014) Three-dimensional principal strain 
analysis for characterizing subclinical changes in left ventricular 
function. J Am Soc Echocardiogr 27(10):1041–1050
 5. Bernard A et al (2017) 3D echocardiographic reference ranges for 
normal left ventricular volumes and strain: results from the EACVI 
NORRE study. Eur Heart J Cardiovasc Imaging 18(4):475–483
 6. Truong VT et al (2019) Normal ranges of left ventricular strain 
by three-dimensional speckle-tracking echocardiography in adults: 
a systematic review and meta-analysis. J Am Soc Echocardiogr 
32(12):1586–1597
 7. Yuda S et al (2014) Inter-vendor variability of left ventricular 
volumes and strains determined by three-dimensional speckle 
tracking echocardiography. Echocardiography 31(5):597–604
 8. Muraru D et  al (2014) Left ventricular myocardial strain by 
three-dimensional speckle-tracking echocardiography in healthy 
subjects: reference values and analysis of their physiologic and 
technical determinants. J Am Soc Echocardiogr 27(8):858–871
 9. van Grootel RWJ et al (2017) Echocardiographic chamber quan-
tification in a healthy Dutch population. Netherlands Heart J 
25(12):682–690
 10. van Grootel RWJ et al (2018) In-depth echocardiographic analy-
sis of left atrial function in healthy adults using speckle tracking 
echocardiography and volumetric analysis. Echocardiography 
35(12):1956–1965
 11. McGhie JS et al (2017) Quantitative assessment of the entire right 
ventricle from one acoustic window: an attractive approach. Eur 
Heart J Cardiovasc Imaging 18(7):754–762
 12. Lang RM et al (2015) Recommendations for cardiac chamber 
quantification by echocardiography in adults: an update from the 
American Society of Echocardiography and the European Asso-
ciation of Cardiovascular Imaging. Eur Heart J Cardiovasc Imag-
ing 16(3):233–270
 13. Satriano A et al (2017) Clinical feasibility and validation of 3D 
principal strain analysis from cine MRI: comparison to 2D strain 
by MRI and 3D speckle tracking echocardiography. Int J Cardio-
vasc Imaging 33(12):1979–1992
 14. Støylen A, Mølmen HE, Dalen H (2019) Left ventricular global 
strains by linear measurements in three dimensions: interrelations 
and relations to age, gender and body size in the HUNT Study. 
Open Heart 6(2):e001050
 15. Gayat E et al (2011) Reproducibility and inter-vendor variability of left 
ventricular deformation measurements by three-dimensional speckle-
tracking echocardiography. J Am Soc Echocardiogr 24(8):878–885
 16. Amzulescu MS et al (2019) Myocardial strain imaging: review of 
general principles, validation, and sources of discrepancies. Eur 
Heart J Cardiovasc Imaging 20(6):605–619
 17. Voigt JU et al (2015) Definitions for a common standard for 2D 
speckle tracking echocardiography: consensus document of the 
EACVI/ASE/Industry Task Force to standardize deformation 
imaging. J Am Soc Echocardiogr 28(2):183–193
 18. Badano LP et al (2013) Use of three-dimensional speckle track-
ing to assess left ventricular myocardial mechanics: inter-vendor 
consistency and reproducibility of strain measurements. Eur Heart 
J Cardiovasc Imaging 14(3):285–293
 19. Kleijn SA et al (2015) Normal reference values of left ventricular 
strain using three-dimensional speckle tracking echocardiography: 
results from a multicentre study. Eur Heart J Cardiovasc Imaging 
16(4):410–416
 20. Yingchoncharoen T et al (2013) Normal ranges of left ventricular 
strain: a meta-analysis. J Am Soc Echocardiogr 26(2):185–191
 21. Xia JZ et al (2014) Left ventricular strain examination of different 
aged adults with 3D speckle tracking echocardiography. Echocar-
diography 31(3):335–339
 22. Xu T-Y et al (2014) Three-dimensional speckle strain echocardi-
ography is more accurate and efficient than 2D strain in the evalu-
ation of left ventricular function. Int J Cardiol 176(2):360–366
 23. Ringle A et al (2017) Evolution of subclinical myocardial dysfunc-
tion detected by two-dimensional and three-dimensional speckle 
tracking in asymptomatic type 1 diabetic patients: a longterm 
follow-up study. Echo Res Pract 4(4):73–81
 24. Rozenbaum Z et al (2019) Association of body mass index and 
diastolic function in metabolically healthy obese with preserved 
ejection fraction. Int J Cardiol 277:147–152
 25. Gandhi S et al (2018) Automation, machine learning, and artificial 
intelligence in echocardiography: a brave new world. Echocardi-
ography 35(9):1402–1418
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
Table 6  Probable sources of intervendor variability in speckle tracking echocardiography  (Adapted from 16)
3D-STE three-dimensional speckle tracking echocardiography, ROI region of interest
Modality and US system related (2D-STE 
versus 3D-STE or inter-vendor)
• Technical differences in image acquisition and processing
• Spatial and temporal resolution
Software-related • Strain definitions (eg. tangential vs area strain)
• Calculation of global values (peak vs simultaneous)
• Layer preference (only endocardial versus fixed thickness ROI vs adjustable thickness ROI track-
ing)
• Definition of end-diastole and end-systole (ECG, valvular closure/openings, inflow/outflow)
